Radiopharmaceutical, a medicinal product intended for PET/CT scan examination and diagnosis n early stages of prostatic cancer.
Clinical trial [18F] -fluorocholin inj was initiated by CZECRIN in cooperation with Masaryk Memorial Cancer Institute (MMCI) Phase I Unit and currently is the product submitted and waiting for registration in Czech Republic.
